down arrow

Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
894.60
-7.6 (-0.84%)
BSENSE

Dec 05

BSE+NSE Vol: 10.55 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,910.15
1,710.72
1,769.64
1,692.74
1,647.98
1,561.73
1,516.98
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,910.15
1,710.72
1,769.64
1,692.74
1,647.98
1,561.73
1,516.98
Raw Material Cost
463.14
431.27
426.20
446.91
393.14
405.93
337.38
Purchase of Finished goods
126.82
109.16
92.64
120.18
102.64
95.50
110.54
(Increase) / Decrease In Stocks
-74.04
-133.02
11.77
-127.55
-66.66
-107.34
-68.55
Employee Cost
437.54
422.77
393.59
397.52
391.47
379.77
401.85
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
641.00
599.19
573.52
595.46
588.12
551.04
475.70
Total Expenditure (Excl Depreciation)
1,594.46
1,429.37
1,497.72
1,432.52
1,408.71
1,324.90
1,256.92
Operating Profit (PBDIT) excl Other Income
315.69
281.35
271.92
260.22
239.27
236.83
260.06
Other Income
6.91
6.50
14.19
9.50
16.74
2.10
3.60
Operating Profit (PBDIT)
322.60
287.85
286.11
269.72
256.01
238.93
263.66
Interest
24.23
23.52
24.52
22.26
18.81
13.18
10.94
Exceptional Items
0.00
0.00
0.00
0.00
12.87
0.00
0.00
Gross Profit (PBDT)
298.37
264.33
261.59
247.46
250.07
225.75
252.72
Depreciation
76.07
73.77
68.99
70.04
70.51
69.04
69.48
Profit Before Tax
223.72
190.11
191.94
177.78
180.42
157.03
182.85
Tax
40.01
36.48
35.31
40.08
27.28
22.49
4.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
182.29
154.08
157.29
137.34
152.28
134.22
178.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
182.29
154.08
157.29
137.34
152.28
134.22
178.60
Share in Profit of Associates
1.42
-0.45
-0.66
0.36
0.86
0.32
-0.39
Minority Interest
-1.00
-0.75
-0.26
-0.72
-0.27
-0.17
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
184.71
154.38
156.89
138.42
153.41
134.71
178.21
Equity Capital
39.31
39.31
39.31
39.31
39.31
39.31
39.31
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
9.4
7.85
7.98
7.04
7.81
6.85
9.07
Diluted Earnings per share
9.4
7.85
7.98
7.01
7.79
6.84
9.07
Operating Profit Margin (Excl OI)
16.53%
16.45%
15.37%
15.37%
14.52%
15.16%
17.14%
Gross Profit Margin
15.62%
15.45%
14.78%
14.62%
15.17%
14.46%
16.66%
PAT Margin
9.62%
8.98%
8.85%
8.13%
9.29%
8.61%
11.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 15.91% vs 3.33% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 20.40% vs 12.34% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 31.94% vs 14.90% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is 28.81% vs 19.89% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Alembic Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,910.15
537.47
1,372.68
255.40%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,910.15
537.47
1,372.68
255.40%
Raw Material Cost
463.14
203.53
259.61
127.55%
Purchase of Finished goods
126.82
0.00
126.82
(Increase) / Decrease In Stocks
-74.04
-63.41
-10.63
-16.76%
Employee Cost
437.54
162.79
274.75
168.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
641.00
88.73
552.27
622.42%
Total Expenditure (Excl Depreciation)
1,594.46
391.64
1,202.82
307.12%
Operating Profit (PBDIT) excl Other Income
315.69
145.83
169.86
116.48%
Other Income
6.91
15.33
-8.42
-54.92%
Operating Profit (PBDIT)
322.60
161.16
161.44
100.17%
Interest
24.23
9.35
14.88
159.14%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
298.37
151.81
146.56
96.54%
Depreciation
76.07
39.75
36.32
91.37%
Profit Before Tax
223.72
112.05
111.67
99.66%
Tax
40.01
28.21
11.80
41.83%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
182.29
83.84
98.45
117.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
182.29
83.84
98.45
117.43%
Share in Profit of Associates
1.42
0.00
1.42
Minority Interest
-1.00
0.00
-1.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
184.71
83.84
100.87
120.31%
Equity Capital
39.31
20.98
18.33
87.37%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
9.40
4.00
5.40
135.00%
Diluted Earnings per share
9.40
3.93
5.47
139.19%
Operating Profit Margin (Excl OI)
16.53%
27.13%
0.00
-10.60%
Gross Profit Margin
15.62%
28.25%
0.00
-12.63%
PAT Margin
9.62%
15.60%
0.00
-5.98%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,910.15 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 11.66% vs -3.33% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 15.91% vs 3.33% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 184.71 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 19.65% vs -1.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.40% vs 12.34% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 315.69 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 12.21% vs 3.47% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 31.94% vs 14.90% in Sep 2024

Quarterly - Interest
Interest 24.23 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.02% vs -4.08% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 28.81% vs 19.89% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.53%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."